Michael Morrison

University of Oxford - Centre for Health, Law and Emerging Technologies

University of Oxford

Oxford, OX2 7DD

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

132

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Key Challenges in Bringing CRISPR-Mediated Somatic Cell Therapy into the Clinic

Genome Medicine, 2017
Number of pages: 4 Posted: 18 Oct 2017
University of Tasmania, Georgetown University Law Center, University of Oxford - Centre for Health, Law and Emerging Technologies, University of Illinois College of Law, University of Tasmania - Faculty of Law, University of Tasmania, University of Alberta - Faculty of Public Health, University of Tasmania, University of Tasmania - Faculty of Law, University of Manchester - Centre for Social Ethics and Policy, University of Tasmania - Menzies Institute for Medical Research, Swinburne University of Technology, University of New South Wales (UNSW), Flinders University, University of Tasmania, University of Tasmania, King’s College London, Addgene, Osaka, Dept of Biomedical Ethics & Public Policy, Graduate School of Medicine, McGill University, Kyoto University, University of Western Australia - Centre for Ophthalmology and Visual Science, The University of Sydney, University of Tasmania, Geisinger Health System - Bioethics Research and Deakin University - School of Medicine
Downloads 66 (501,169)

Abstract:

Loading...

Genome Editing, CRISPR, Somatic Cell Therapy, Genetic Diseases, Gene Therapy

2.

Governing Stem Cells: Regenerative Medicine in Europe - The Vision and Recommendations From the EUCelLEX Project

Governing Stem Cells: Regenerative Medicine in Europe,The Vision and Recommendations From the EUCelLEX Project, Edited by Emmanuelle Rial-Sebbag (EUCelLEX Consortium), December 2018
Number of pages: 113 Posted: 02 Apr 2019
Research Fellow, Medical University of Graz, Catholic University of Leuven - Faculty of Medicine - Center for Biomedical Ethics and Law, Legal Pathways Life Sciences Law, University of Angers - French Institute of Health and Medical Research (INSERM), BBMRI-ERIC, Leibniz Universität Hannover, Dpt. of Human Genetics, University of Miami Miller School of Medicine, University of Oxford - Centre for Health, Law and Emerging Technologies, McGill University - Centre for Genomics and Policy, Leibniz Universität Hannover, University of Oxford - Centre for Health, Law and Emerging Technologies, IFRIS, KU Leuven, Medical University of Graz, Inserm, UMR 1027, Central European University (CEU), KU Leuven - Interfaculty Center for Biomedical Ethics and Law, SciencesPo, Hungarian Academy of Sciences CSS Institute for Legal Studies and Medical University of Graz - Diagnostic and Research Institute for Pathology
Downloads 63 (513,250)

Abstract:

Loading...

Governing Stem Cells, Regenerative Medicine, EUCelLEX project

3.

Patent Power in Biomedical Innovation: Technology Governance in Biomodifying Technologies

Bicudo, E, Morrison M, Li P, Faulkner A, Webster A, Mourby M, Kaye J ‘Patent power in biomedical innovation: Technology governance in biomodifying technologies’ (2022) The Journal of World Intellectual Property 1-22
Number of pages: 25 Posted: 29 Nov 2022
University of Sussex - Department of International Relations, University of Oxford - Centre for Health, Law and Emerging Technologies, University of Sussex Law School, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and University of Oxford - Centre for Health, Law and Emerging Technologies
Downloads 3 (930,613)

Abstract:

Loading...

gene editing; iPSCs; 3D bioprinting; patents; technology governance; experimentality